Share Capital
VC Fund
Shenzhen, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
- Total investments:
- 112
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Share Capital invests in
Stages Share Capital invests in
Countries Share Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $161k–$7.3M
- Series A
- $1.4M–$17M
- Series B
- $2.9M–$93M
Investment Focus
Industry
- Health Care 25 (22%)
- Medical 23 (21%)
- Biotechnology 14 (13%)
- Manufacturing 9 (8%)
- Internet 8 (7%)
Stage
- Series A 37 (33%)
- Series B 16 (14%)
- Seed 15 (13%)
- Angel 13 (12%)
- Venture - Series Unknown 10 (9%)
Country
- China 81 (72%)
- United States 5 (4%)
- Colombia 1 (1%)
- Hong Kong 1 (1%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Cui Xinxin
Partner and Co-Founder
|
Partner and Co-Founder | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health. | Series D / Dec 03, 2025 | ||
|
SuperDimension Power
|
SuperDimension is dedicated to creating leading embodied intelligent brains and robot bodies. | Seed / Oct 30, 2025 | |
| Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment. | $14M / Series B / Aug 26, 2025 | ||
|
Hainan Yayoi
|
Hainan Yayoi is a leading precision breeding service provider, specializing in advanced genetic techniques and cutting-edge breeding technologies to improve agricultural productivity, enhance crop resilience, and support sustainable farming practices across a wide range of crops | Seed / Aug 11, 2025 | |
| Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment. | $13.7M / Series A / Oct 24, 2023 | ||
| Depp CNC is a research and development manufacturer of CNC machine tools and core accessories. | $1.5M / Angel / Apr 21, 2023 | ||
| Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries. | $13M / Series B / Mar 02, 2023 | ||
| HoyTrabajas is an HR-Tech solution designed to assist companies in Latin America facing high turnover rates in swiftly attracting and retaining low-skilled talent within a timeframe of fewer than 48 hours. | $5M / Seed / Oct 13, 2022 | ||
| Upward Technology is a developer of intelligent new material application products. | Seed / Sep 07, 2022 | ||
| Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries. | $7.9M / Series A / Mar 31, 2022 | ||
| See all 112 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Share Capital invest in?
Share Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 112 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Share Capital's check size?
Share Capital typically joins rounds of $161k–$7.3M at Seed, $1.4M–$17M at Series A and $2.9M–$93M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Share Capital participates in.
How do I contact Share Capital?
Public channels for Share Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Share Capital?
The team at Share Capital includes Cui Xinxin (Partner and Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
